GE HealthCare is said to near $1B Sofie Biosciences deal (GEHC:NASDAQ)
· seekingalpha.com
GE HealthCare is in talks to buy Sofie Biosciences for ~$1B, boosting radiopharmaceuticals for PET scans and recurring revenue—get the investor take now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...